Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Evaluation and Management of Kidney Pole Findings

Initial Evaluation

  • The American Urological Association recommends comprehensive evaluation for kidney pole findings, including appropriate imaging, consideration of renal mass biopsy for solid lesions >2cm, and treatment decisions based on mass characteristics, with active surveillance recommended for asymptomatic masses <2cm and intervention for symptomatic or larger lesions 1
  • Ultrasound is typically the first imaging modality used for kidney pole findings, allowing visualization of both kidneys in longitudinal and transverse planes for comparison and assessment 2
  • Cross-sectional imaging with CT or MRI should be obtained to further characterize the finding, especially to distinguish between solid masses, complex cysts, and simple cysts 3, 4
  • For solid or Bosniak 3/4 complex cystic renal masses, a urologist should lead the counseling process and consider all management strategies 1
  • Renal mass biopsy (RMB) should be considered when the mass is suspected to be hematologic, metastatic, inflammatory, or infectious, or when the risk/benefit analysis for treatment is equivocal and additional risk stratification would alter management 1, 5
  • RMB should also be considered for solid or Bosniak 3/4 complex cystic renal masses >2cm 5

Management Algorithm Based on Finding Type

1. Solid Renal Masses

  • For masses <2cm, active surveillance (AS) is an appropriate initial management option, with repeat imaging in 3-6 months to assess for interval growth 1, 5
  • For masses 2-4cm, partial nephrectomy is generally preferred to preserve renal function, with a minimally invasive approach considered when it would not compromise oncologic, functional, and perioperative outcomes 1
  • For masses >4cm, radical nephrectomy or partial nephrectomy may be considered, depending on tumor characteristics and surgeon expertise, with adrenalectomy performed if imaging and/or intraoperative findings suggest metastasis or direct invasion 1, 3

2. Complex Cystic Lesions (Bosniak 3/4)

  • A similar management approach to solid masses is recommended, with consideration of patient age, comorbidities/frailty, and life expectancy, as well as potential oncologic benefits versus risks of intervention 1, 4
  • Active surveillance with periodic reassessment may be considered for selected patients 4

3. Simple Cysts or Bosniak 1/2 Cysts

  • Generally require no intervention unless symptomatic, with follow-up imaging considered based on size and symptoms 6, 7

4. Stones in Lower Pole

  • For stones <10mm, flexible ureteroscopy (fURS) or shock wave lithotripsy (SWL) are first-line treatments 6, 7
  • For stones 10-20mm, fURS and percutaneous nephrolithotomy (PCNL) are suggested options 6, 7
  • For stones >20mm, PCNL is the first option regardless of location 6, 7

Follow-up Recommendations

For Benign Lesions

  • Patients with pathologically-proven benign renal masses should undergo occasional clinical evaluation and laboratory testing for sequelae of treatment, but most do not require routine periodic imaging 4

For Malignant Lesions

  • Periodic medical history, physical examination, laboratory studies, and imaging are recommended to detect signs and symptoms of metastatic spread and/or local recurrence, with laboratory testing including serum creatinine, estimated glomerular filtration rate, and urinalysis 4
  • Additional laboratory evaluations may be obtained if advanced disease is suspected, and bone scan is only indicated if bone pain, elevated alkaline phosphatase, or radiographic findings suggestive of bony neoplasm are present 3, 4
  • Brain/spine imaging is indicated for patients with acute neurological signs or symptoms 3

Special Considerations

  • In patients with hereditary renal cancer syndromes, consider genetic evaluation, especially if age at presentation is ≤46 years 1
  • Pathologic evaluation of the adjacent renal parenchyma should be performed after partial or radical nephrectomy to assess for possible nephrologic disease, particularly for patients with chronic kidney disease (CKD) 1
  • When performing partial nephrectomy, prioritize preservation of renal function while ensuring negative surgical margins 1

Common Pitfalls to Avoid

  • Overlooking the possibility of hereditary syndromes in younger patients with renal masses 1
  • Performing unnecessary bone scans in asymptomatic patients with normal alkaline phosphatase levels 3
  • Neglecting to evaluate the bladder when assessing kidney findings, as distal ureteral obstruction may be present 2
  • Overtreatment of small, asymptomatic masses in elderly patients with significant comorbidities 5